about
Scorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineeringOxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand designSemienzymatic Cyclization of Disulfide-rich Peptides Using Sortase AExpression and biological activity of the cystine knot bioinsecticide PA1b (Pea Albumin 1 Subunit b)Gene coevolution and regulation lock cyclic plant defence peptides to their targetsScaffold optimization in discontinuous epitope containing protein mimics of gp120 using smart libraries.Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications.Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imagingCone snail venomics: from novel biology to novel therapeutics.Centipede venoms as a source of drug leads.Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.Database-Guided Discovery of Potent Peptides to Combat HIV-1 or SuperbugsIntein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis.Chemical synthesis, backbone cyclization and oxidative folding of cystine-knot peptides: promising scaffolds for applications in drug design.Joseph Rudinger memorial lecture: discovery and applications of cyclotides.Cyclotides as grafting frameworks for protein engineering and drug design applications.Immunosuppressive peptides and their therapeutic applications.Native chemical ligation: a boon to peptide chemistry.Review cyclic peptides on a merry-go-round; towards drug design.Strategies to stabilize cell penetrating peptides for in vivo applications.Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.Plant cystine-knot peptides: pharmacological perspectives.Discovery, structure, function, and applications of cyclotides: circular proteins from plants.Discovery and optimization of peptide macrocycles.Molecular cloning and in silico characterization of knottin peptide, U2-SCRTX-Lit2, from brown spider (Loxosceles intermedia) venom glands.High-affinity cyclic peptide matriptase inhibitorsThe Importance of Amino Acid Composition in Natural AMPs: An Evolutional, Structural, and Functional PerspectiveThe self-association of the cyclotide kalata B2 in solution is guided by hydrophobic interactions.Chemical Proteomics for Target Discovery of Head-to-Tail Cyclized Mini-Proteins.Anthelminthic activity of the cyclotides (kalata B1 and B2) against schistosome parasites.Twin disulfides for orthogonal disulfide pairing and the directed folding of multicyclic peptides.Limiting Assumptions in the Design of Peptidomimetics.Single-step purification of cyclotides using affinity chromatography.Coupling Plant-Derived Cyclotides to Metal Surfaces: An Antibacterial and Antibiofilm Study.Mechanism-based selection of a potent kallikrein-related peptidase 7 inhibitor from a versatile library based on the sunflower trypsin inhibitor SFTI-1Disulfide Formation Strategies in Peptide Synthesis
P2860
Q26853728-97175C1F-9156-4402-8D00-0D48B9B94FEFQ27680631-5D9112A2-269A-4D85-9DFC-5FFE88D4573DQ27681346-AF332B75-DE77-4074-97F5-416FF5F50657Q28536759-ECFF5CBA-8ECB-46E6-A974-48D738FF0FFFQ29037864-A8A722B6-F6A9-4A8E-9B5D-B2921B9DBA20Q31112205-814C63A1-C2DB-4536-9A25-5473762790DFQ33612302-79FCDE79-0B4F-407D-988F-9CB87042B785Q34662001-FC7BAEC6-DDEC-4192-95F2-D7DFE5333249Q35432836-59271BFA-5BC5-4BFC-B1AF-A3AF7260EB45Q36128041-7EAB47AE-AFF9-4612-A0CB-C8A48331879BQ36821577-F6777A1F-A5A8-4E43-AD8E-73CFBE3F437AQ37277482-51636024-B4BC-419E-A3D8-42385285B66FQ37620427-1312EEEB-7DA6-4D6B-A18E-413AD0A338BFQ38055326-B87025A9-0C64-4C1B-8EEE-92D19E3C9A66Q38112084-5B8A66DF-F868-43F3-9F1F-2B7BE5AA3B13Q38124801-C4CC6E9B-D3F7-40AE-9629-83047C89EDA5Q38170857-EF64F744-479E-4F40-B1C8-8DCAA2BF4B81Q38249204-D2CFDB0D-3234-4684-8AE5-D81FA4774C7BQ38476515-60695460-781F-4639-A765-0895BC6BE755Q38602460-568BED35-2B49-46A2-B772-79F3557952B9Q38762672-1809A6C6-7B81-40B4-8E3E-3EF7D176ADEFQ38778694-39FFB646-061E-41DE-B17C-D2D88C72BFBEQ38843873-5624ADA8-7015-460E-A5FD-2B3D26E53430Q38975684-4872533C-EB16-4D48-9497-2468609EA2B1Q39528259-20CA3EB4-A44E-42C9-9F30-C8060D9E2BCBQ40601659-400C4362-55D1-4B56-BCCE-5287CFEE9768Q42140998-4CBEC4B5-0A2A-4212-B0DC-514F74A14CB2Q42280887-285044A3-0979-4998-8269-78A8BB986406Q42654389-C915B053-900D-4436-85DC-699DCD9A35E3Q44243940-F07A6D43-E7FD-47F9-BB1C-736F75A3D8DFQ45023232-F7E991C1-34DD-40D5-A0B3-96213F3990F5Q47850453-1ACF56D0-40BD-4707-BEEE-1B90C1E344B5Q51240701-5A2510FC-428B-4CC3-9C08-A191BC6CC234Q51742192-EE7922E3-BFA7-435D-9235-9FD871B04BB2Q58022615-1F4E0C23-D83C-4F57-A5B4-4FC274F20AA4Q58034989-FE63CF6B-E103-4A18-9563-CC23D7BD324A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cyclotides as a basis for drug design.
@en
Cyclotides as a basis for drug design.
@nl
type
label
Cyclotides as a basis for drug design.
@en
Cyclotides as a basis for drug design.
@nl
prefLabel
Cyclotides as a basis for drug design.
@en
Cyclotides as a basis for drug design.
@nl
P2860
P50
P1476
Cyclotides as a basis for drug design.
@en
P2093
Masa Cemazar
P2860
P304
P356
10.1517/17460441.2012.661554
P407
P577
2012-02-21T00:00:00Z